Full-Time
Senior Software Engineer-Mobile
India
Posted on 11/14/2025
Biofourmis
51-200 employees
Predictive health platform enabling hospital-at-home monitoring
No salary listed
Bengaluru, Karnataka, India
In Person
 Software Engineering (1) |
|---|
- Bachelor’s or Master’s degree in Computer Science, Engineering, or related field.
- 8+ years of professional experience in mobile application development.
- Expertise in building cross-platform mobile apps, optimizing performance, and managing state.
- Strong proficiency in native Android development (Java/Kotlin): deep understanding of Android SDK, architecture components, and platform guidelines.
- Solid understanding of mobile UI/UX principles and responsive design.
- Experience with RESTful APIs, GraphQL, and mobile app security best practices.
- Proven experience with version control systems (e.g., Git) and agile methodologies.
- Excellent problem-solving, communication, and leadership skills.
- Architect and design end-to-end mobile solutions using native Android frameworks.
- Lead and mentor development teams, providing technical guidance and best practices.
- Collaborate with product managers, UX/UI designers, and backend teams to define requirements and deliverables.
- Evaluate and recommend new tools, frameworks, and best practices for mobile development.
- Ensure code quality, performance, and maintainability through code reviews and automated testing.
- Troubleshoot and resolve complex technical issues across platforms.
- Oversee the integration of third-party APIs and services.
- Drive the adoption of CI/CD pipelines and DevOps practices for mobile deployments.
- Stay updated with the latest industry trends and advancements in mobile technology.
- Working knowledge of BLE device integration is a plus
- Familiarity with iOS development (Swift/Objective-C) is a plus.
- Contributions to open-source projects or published apps on Google Play/App Store.
- Experience with mobile analytics, crash reporting, and performance monitoring tools.
Biofourmis delivers hospital-level care at home by combining a digital health platform with biosensors and deep learning. Hospitals, pharma firms, and patients use its predictive analytics to remotely monitor patients, track vital data, and personalize care. The platform works through wearable sensors that collect data and AI models that continuously analyze it to predict medical events and guide interventions, enabling proactive care outside the hospital. Compared to traditional remote monitoring, Biofourmis focuses on deep learning-based predictive analytics and end-to-end care delivery, plus partnerships with pharmaceutical companies to optimize drug efficacy and outcomes. The company aims to prevent costly health events, improve patient outcomes, and extend hospital-level care into home settings by selling subscriptions and service contracts to healthcare systems and collaborating with drug developers.
Company Size
51-200
Company Stage
Series D
Total Funding
$463.6M
Headquarters
Boston, Massachusetts
Founded
2015
Simplify's Take
What believers are saying
- CopilotIQ merger launches end-to-end AI in-home care platform across care stages.
- Lee Health partnership expands remote monitoring and hospital-at-home services.
- ActiGraph acquisition of Connect boosts clinical trial AI capabilities.
What critics are saying
- ActiGraph acquisition eliminates Biofourmis Connect pharmaceutical revenue.
- CopilotIQ merger integration fails due to technology incompatibilities.
- ActiGraph steals biopharma clients with superior device-agnostic platform.
What makes Biofourmis unique
- Biofourmis analyzes 120 biomarkers in real-time using AI for predictive care.
- BiovitalsHF® is FDA Breakthrough Device for heart failure digital therapeutics.
- Platform integrates Epic EHR for seamless hospital-at-home monitoring.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Paid Vacation
Paid Holidays
Remote Work Options
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↓ -3%2 year growth
↑ 4%AdventHealth launches new acute care-at home program.
PENSACOLA, Fla. and NASHVILLE, Tenn., Jan. 7, 2025 /PRNewswire/ -- ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry. The combined solution will create a market-leading, unified software and data ecosystem for the modernization of clinical research throughout the drug-product lifecycle and across therapeutic areas.This strategic acquisition enables ActiGraph to deliver the industry's most comprehensive and trusted digital health solution, supporting a wide range of clinical use cases with a device-agnostic platform and patient-centric approach. ActiGraph's leading-edge, medical-grade LEAP wearable technology will be integrated alongside other medical-grade devices, including ECG, pulse oximetry, spirometry, and blood pressure, powered by regulatory-cleared algorithms. ActiGraph is further elevating its leadership in the remote and real-time capture of continuous, high-precision digital health data and will address new areas of high unmet need, such as objective assessments of pain and prediction of Cytokine Release Syndrome (CRS) risk in oncology and immunology trials.Boosted by more than 30 proprietary AI-driven algorithms and practical expertise working with the FDA and EMA, ActiGraph will expand its support of biopharma clients throughout the full life cycle of their assets with bespoke digital biomarker programs
ActiGraph Acquires Biofourmis Life Science Business. by Fred Pennic 01/07/2025 Leave a Comment. What You Should Know: – ActiGraph, a global leader in wearable digital health technology, announced the acquisition of Biofourmis Connect, a division of Biofourmis specializing in AI-powered digital trial platforms for the life science industry. Financial terms of the acquisition were not disclosed.– The acquisition combines ActiGraph’s expertise in wearable technology with Biofourmis Connect’s advanced analytics capabilities, creating a comprehensive and unified solution for modernizing clinical research.Acquisition ImpactThe acquisition enables ActiGraph to deliver a market-leading, device-agnostic platform that supports a wide range of clinical use cases throughout the drug development lifecycle. By integrating Biofourmis Connect’s AI-driven technology, ActiGraph enhances its ability to capture and analyze high-precision digital health data, leading to more efficient and patient-centric clinical trials.“The life science industry has sought out digital innovations to improve clinical development productivity, but they need end-to-end support solidified by operational, analytical, and regulatory expertise. The synergies with Biofourmis Connect will allow ActiGraph to transform its portfolio by adding AI-driven analytics into a digital, device-agnostic platform, allowing our clients to benefit from a true scalable solution with a seamless experience for patients and clinical sites,” said Jeremy Wyatt, CEO of ActiGraph. “We are especially excited to welcome the seasoned Biofourmis Connect employees to our global team, strengthening our capacity for growth and innovation.”
Healthtech unicorn Biofourmis axed about 30 employees from its Singapore and India offices at the end of November, people familiar with the matter told Tech in Asia. However, the exact number of retrenched staff per country remains unclear. The move comes just a month after US-headquartered Biofourmis and General Atlantic-backed CopilotIQ announced a merger to form an AI-driven platform aimed at providing in-home healthcare. Tech in Asia has reached out to Biofourmis for comment.Photo credit: BiofourmisBiofourmis underwent two rounds of layoffs last year. The first occurred before Kuldeep Singh Rajput, the company’s CEO at the time, stepped down in August 2023. The second involved 130 employees and took place months later in October, when the firm began winding down operations in Singapore
To enhance the experience, Biofourmis is integrating with Lee Health's Epic Electronic Health Record (EHR) system, ensuring critical patient data is accessible for continuity of care and efficient management of acute and post-acute care, even from a patient's home.